Company Overview of Riverside Therapeutics Inc.
Riverside Therapeutics, Inc., a development stage biopharmaceutical company, does not have significant operations. It seeks to acquire the rights to develop and commercialize therapeutic drug candidates designed to treat unmet medical needs in the area of oncology. The company may also pursue opportunities that treat, prevent, or detect other human illnesses, such as cardiology or immunology. Riverside Therapeutics was incorporated in May 2004 and is based in New York City.
787 7th Avenue 48th Floor
New York, NY 10019
Founded in 2004
Key Executives for Riverside Therapeutics Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Riverside Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.